| Principles for designing an optimal mRNA lipid nanoparticle vaccine E Kon, U Elia, D Peer Current opinion in biotechnology 73, 329-336, 2022 | 154 | 2022 |
| Immune checkpoint inhibitor combinations: Current efforts and important aspects for success E Kon, I Benhar Drug Resistance Updates 45, 13-29, 2019 | 98 | 2019 |
| Nanotechnology-based strategies against SARS-CoV-2 variants X Huang, E Kon, X Han, X Zhang, N Kong, MJ Mitchell, D Peer, W Tao Nature Nanotechnology 17 (10), 1027-1037, 2022 | 82 | 2022 |
| Therapeutic mRNA delivery to leukocytes Y Granot-Matok, E Kon, N Dammes, G Mechtinger, D Peer Journal of Controlled Release 305, 165-175, 2019 | 54 | 2019 |
| Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects E Kon, N Ad-El, I Hazan-Halevy, L Stotsky-Oterin, D Peer Nature reviews clinical oncology 20 (11), 739-754, 2023 | 44 | 2023 |
| A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium E Kon, Y Levy, U Elia, H Cohen, I Hazan-Halevy, M Aftalion, A Ezra, ... Science advances 9 (10), eadg1036, 2023 | 32 | 2023 |
| Endosomal escape: A bottleneck for LNP-mediated therapeutics S Chatterjee, E Kon, P Sharma, D Peer Proceedings of the National Academy of Sciences 121 (11), e2307800120, 2024 | 20 | 2024 |
| Resveratrol enhances mRNA and siRNA lipid nanoparticles primary CLL cell transfection E Kon, I Hazan-Halevy, D Rosenblum, N Cohen, S Chatterjee, N Veiga, ... Pharmaceutics 12 (6), 520, 2020 | 16 | 2020 |
| CRISPR editing in the lung with novel lipids U Elia, E Kon, D Peer Nature Biotechnology 41 (10), 1387-1388, 2023 | 3 | 2023 |
| Therapeutic application of circular RNA aptamers in a mouse model of psoriasis SK Guo, CX Liu, YF Xu, X Wang, F Nan, Y Huang, S Li, S Nan, L Li, E Kon, ... Nature Biotechnology, 1-11, 2024 | 1 | 2024 |
| Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis C Huang, H Jiang, J Dong, L Jiang, J Li, J Xu, T Cui, L Wang, X Li, G Feng, ... Stem Cell Reports, 2024 | | 2024 |
| Extrahepatic delivery of RNA to immune cells I Hazan-Halevy, D Landesman-Milo, E Kon, N Dammes, D Peer RNA Therapeutics, 57-86, 2022 | | 2022 |
| Transient Combustion Modeling for Hypergolic Engines D Hoffpauir | | |
| mRNA VACCINES: USING TINY PARTICLES TO FIGHT VIRUSES HOWV WORK | | |
